Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Improving Chronic Disease Outcomes Across the Lifespan by Addressing Structural Racism

Authors not listed

University of Massachusetts, Worcester · 2025

Abstract

The goal of this clinical trial is to learn if the implementation of the WE CARE social determinants of health (SDOH) screening and referral intervention with an antiracist lens in primary care settings can lead to a meaningful decrease in chronic disease by monitoring conditions such as hypertension, diabetes, depression, hyperlipidemia, and asthma through clinical measures. The main question it aims to answer is: Does the WE CARE SDOH screening and referral intervention applying an antiracism lens informed implementation strategies have the potential to reduce racial/ethnic health inequities in chronic diseases for minoritized patients?

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-13 MST

Cite this

APA
Anonymous. (2025). Improving Chronic Disease Outcomes Across the Lifespan by Addressing Structural Racism. <em>University of Massachusetts, Worcester</em>. https://clinicaltrials.gov/study/NCT06903897
Vancouver
Anonymous. Improving Chronic Disease Outcomes Across the Lifespan by Addressing Structural Racism. University of Massachusetts, Worcester. 2025.
BibTeX
@misc{anon2025Improv, title = {Improving Chronic Disease Outcomes Across the Lifespan by Addressing Structural Racism}, author = {Anonymous}, journal = {University of Massachusetts, Worcester}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings